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S U M M A R Y
Objectives: To better understand the characteristics of patients with acute melioid community-acquired
pneumonia (CAP) on emergency department (ED) arrival, and the risk factors in patients with acute
melioid CAP that differ from those in patients with severe CAP of causes other than melioidosis.
Methods: This was a retrospective case–control study.
Results: During the study period, a total of 15 patients suffered from acute melioid CAP. Comparison with
60 patients with severe CAP of causes other than melioidosis, revealed that visit to the ED in the rainy
season, shock on arrival, diabetes, poor sugar control with glycemia 250 mg/dl, chest radiograph with
cavity formation, and poor clinical outcome, were signiﬁcantly predominant in patients with acute
melioid CAP. Multivariate logistic regression analysis indicated that poor sugar control with glycemia
250 mg/dl (odds ratio (OR) 38.3, 95% conﬁdence interval (CI) 3.6–406.2; p < 0.01), visiting the ED
during the rainy season (OR 13.7, 95% CI 2.3–80.9; p < 0.01), and shock on ED arrival (OR 18.7, 95% CI 1.8–
192.8; p = 0.01) were independent risk factors for patients with CAP caused by Burkholderia pseudomallei.
Conclusions: Physicians in melioidosis endemic areas should administer antimicrobials covering B.
pseudomallei to patients with CAP who visit the ED during the rainy season, who have poor sugar control
with glycemia 250 mg/dl, and who are in shock on ED arrival, to facilitate timely, appropriate antibiotic
therapy and lower the mortality rate.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Although melioidosis is an endemic disease in Southeast Asia
and northern Australia, it has emerged as a global problem due to
an increase in worldwide travel.1 This infection usually occurs
following percutaneous inoculation or inhalation of Burkholderia
pseudomallei present in the soil and surface water in endemic
regions.2 Due to the diverse clinical manifestations of melioidosis,
it is nicknamed ‘the great mimicker’.3,4 Pulmonary melioidosis is
the most common clinical presentation of melioidosis,2,5,6 and it
usually presents as community-acquired pneumonia (CAP). The
mortality rate of pulmonary melioidosis is high if not promptly
diagnosed and treated with effective antibiotic therapy.5–9 It
would be useful to determine whether patients are more likely to
have acute melioid CAP at an early stage. Therefore, we conducted
a retrospective study to better understand the demographics and
clinical and laboratory characteristics of patients with acute
melioid CAP arriving at the emergency department (ED).* Corresponding author. Tel.: +886 7 7317123x8304; fax: +886 7 7322402.
E-mail address: lee900@adm.cgmh.org.tw (C.-H. Lee).
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Data were retrospectively collected for patients who visited the
ED of Kaohsiung Chang Gung Memorial Hospital (KCGMH), whose
microbiological cultures were positive for B. pseudomallei, during
the period January 2001 to December 2010. KCGMH is a 2500-bed
facility that serves as a primary care and tertiary referral center in
southern Taiwan. The study was approved by our institutional
review board (No. 97-0599B). The presence of at least one clinical
criterion (fever, dyspnea, cough, leukocytosis), ﬁndings suggestive
of an inﬁltrate on chest radiograph, and the disease contracted in
the community, were needed to make a diagnosis of CAP. Controls
were retrieved from a computer-aided selection of eligible
individuals who had visited the ED with severe CAP due to causes
other than melioidosis and who were admitted to the intensive
care unit. Each subject was age-matched, and the ratio of cases of
acute melioid CAP to control patients was 1:4.
Data retrieved from the medical records included: (1) demo-
graphics (i.e., age, sex, and whether the patient had visited the
hospital during the rainy season), (2) coexisting conditions (i.e.,
neoplastic disease, chronic obstructive lung disease, diabetes
mellitus (DM), renal disease, liver disease, excessive alcohol intake,ses. Published by Elsevier Ltd. All rights reserved.
C.-T. Kung et al. / International Journal of Infectious Diseases 15 (2011) e627–e630e628and cerebrovascular accident), (3) physical examination (i.e.,
temperature, respiratory rate, heart rate, shock on arrival, and
altered mental status), (4) laboratory tests (i.e., C-reactive protein
(CRP), sodium, PaO2, hematocrit, blood urea nitrogen (BUN), and
glucose), (5) chest radiograph (i.e., multilobar involvement,
presence of cavity, and presence of pleural effusion), (6) antimicro-
bial treatments, and (7) ﬁnal outcome. The rainy season in Taiwan
occurs between June and September. Alcoholism was deﬁned as
more than two drinks (20 g) per day in women and more than three
drinks (30 g) per day in men. Shock on arrival was deﬁned as a
systolic blood pressure <90 mmHg, or a decrease of more than
30 mmHg as compared to the baseline systolic blood pressure on
arrival in the ED, coupled with clinical evidence of peripheral
hypoperfusion. Altered mental status was deﬁned as a new onset of
confusion, delirium, obtundation, stupor, or coma. Empirical
antibiotic therapy at adequate dosages was considered appropriate
if the antibiotic was effective against B. pseudomallei,2 which
included imipenem, meropenem, ceftazidime, and amoxicillin–
clavulanic acid. Early mortality was deﬁned as death within 48 h
after presentation to the ED, and before microbiological conﬁrma-
tion of the diagnosis. Overall mortality was deﬁned as the sum of all
patients with death as the ﬁnal clinical outcome. The ﬁnal clinical
outcome was evaluated at the time of hospital discharge.
The Fisher’s exact test was used to assess differences in
dichotomous variables between the two groups. Variables with a
p-value of <0.1 in univariate analyses were separately entered into
a multivariate logistic regression model to identify independent
risk factors to differentiate acute melioid CAP from severe non-
melioid CAP, and odds ratios (OR) and 95% conﬁdence intervals (CI)
were calculated. Variables with a two-tailed p-value of <0.05 in the
multivariate logistic regression were considered statistically
signiﬁcant. Data were analyzed using SPSS for Windows version
10.0 (SPSS Inc., Chicago, IL, USA).
3. Results
A total of 36 patients with melioidosis, 28 males and eight
females, all 18 years of age (mean age 58 years), were identiﬁed
during the study period. Among them, 15 patients (42%), 13 males
and two females with a mean age of 56 years, were diagnosed with
acute melioid CAP. Demographics and clinical characteristics of the
acute melioid CAP patients are shown in Table 1. All 15 patientsTable 1
Demographic and clinical characteristics of 15 patients with acute melioid community
Number/gender/age
(years)/month/year
Underlying
disease/condition
Positive culture
(days after admissio
1/M/60/June/2001 DM, alcoholism Blood (3), urine (4) 
2/M/58/Aug/2001 DM Blood (7) 
3/M/87/July/2002 Stroke Blood (6) 
4/M/60/Sep/2002 DM, LC, HCC Blood (5) 
5/M/50/Sep/2002 DM, alcoholism Blood (4), sputum (
6/M/41/Feb/2003 Alcoholism, CRF Blood (6) 
7/M/35/June/2004 DM, LC, HCC Blood (5) 
8/M/59/Aug/2004 DM Blood (5), sputum (
9/M/65/May/2007 DM, CAD, hypertension Blood (4) 
10/F/52/June/2008a DM Blood (4) 
11/M/58/July/2008 LC Blood (3), sputum (
12/F/47/May/2009 DM Blood (4), urine (3) 
13/M/66/June/2009a Alcoholism, CRF, COPD Blood (4), sputum (
14/M/58/June/2010a DM, LC Blood (4) 
15/M/51/Oct/2010 DM Blood (3) 
CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; CRF, chron
hepatocellular carcinoma; LC, liver cirrhosis; M, male.
a Three patients received appropriate empirical antibiotics before cultures were ava
b Early mortality.had bacteremia, and the time lapses between obtaining blood and
non-blood specimens for culture and the availability of results
indicating B. pseudomallei infection ranged from 3 to 7 and 3 to 6
days, respectively. Ten patients died (overall mortality 66.7%), and
seven (46.7%) died within 48 h of arrival at the ED. Inappropriate
empiric antibiotic therapy was administered to 12 acute melioid
CAP patients (80%). Only three patients (20%) received appropriate
empirical antibiotics (two received meropenem and one received
ceftazidime) before cultures were available, and the two who
received meropenem as empirical therapy survived. A microbio-
logical etiology of the severe non-melioid CAP was identiﬁed in 21
patients (35%). Streptococcus pneumoniae was the most common
pathogen detected, and was found in eight (38.1%) of these 21
patients. Inappropriate empirical antibiotic therapy was adminis-
tered to six of the 21 patients (28.6%). Blood cultures were
performed in all these 60 patients, and 11 (18.3%) had positive
cultures. A total of 23 patients died (overall mortality 38.3%), and
11 (18.3%) died within 48 h of arrival at the ED.
Comparisons of the demographic characteristics, clinical pre-
sentations, coexisting conditions, laboratory test results, and chest
radiograph ﬁndings on arrival at the ED between the two groups are
shown in Table 2. Univariate analysis revealed that acute melioid
CAP patients were more likely to: (1) have visited the ED during the
rainy season, (2) have DM, (3) have poor sugar control with glycemia
250 mg/dl, (4) have shock on arrival at the ED, and (5) have
evidence of cavity formation on chest radiograph. Inappropriate
empirical antibiotic therapy with early and overall mortality was
signiﬁcantly greater in patients with acute melioid CAP. Multivariate
logistic regression analysis indicated that glycemia 250 mg/dl (OR
38.3, 95% CI 3.6–406.2; p < 0.01), visiting the ED during the rainy
season (OR 13.7, 95% CI 2.3–80.9; p < 0.01), and in shock on ED
arrival (OR 18.7, 95% CI 1.8–192.8; p = 0.01) were independent risk
factors for acute melioid CAP on ED arrival.
4. Discussion
B. pseudomallei has been detected in Taiwan,10 and it is probable
that southern Taiwan is an area endemic for melioidosis. Su et al.11
reported that the annual incidence of melioidosis in the Er-Ren
river basin (located in southern Taiwan) in 2005 was 70 cases/
100 000 persons, which is higher than that in areas where
melioidosis is endemic. In this study, we reported 15 sporadic-acquired pneumonia
n)
Shock
on arrival
Rainy season
visit
Outcome
(days of survival
after ED arrival)/
mechanical ventilation
Yes Yes Died (2)b/yes
No Yes Died (47)/yes
Yes Yes Survived/yes
Yes Yes Died (2)b/yes
3) No Yes Died (16)/no
No No Died (1)b/yes
Yes Yes Died (1)b/yes
6) No Yes Survived/no
Yes No Died (1)b/yes
No Yes Survived/no
3) Yes Yes Died (2)b/yes
Yes No Survived/no
3) Yes Yes Died (1)b/yes
Yes Yes Survived/yes
No No Died (22)/no
ic renal failure; DM, diabetes mellitus; ED, emergency department; F, female; HCC,
ilable, and two survived.
Table 2
Comparisons of differences between patients with acute melioid community-acquired pneumonia and patients with severe community-acquired pneumonia of causes other
than melioidosis, on arrival in the emergency department
Variable Patients with acute
melioid CAP
(n = 15), n (%)
Patients with severe CAP
of causes other than
melioidosis (n = 60), n (%)
p-Value
Demographics
Male gender 13 (86.7) 40 (66.7) 0.21
Rainy season visita 11 (73.3) 8 (13.3) <0.01
Coexisting conditions
Malignancy 2 (13.3) 7 (11.7) 1
COPD 1 (6.7) 19 (31.6) 0.06
DM 11 (73.3) 22 (36.7) 0.02
Poor sugar with glycemia 250 mg/dla 10 (66.7) 6 (10) <0.01
Renal disease 2 (13.3) 8 (13.3) 1
Liver disease 4 (26.7) 8 (13.3) 0.24
Alcoholism 4 (26.7) 9 (15) 0.28
Cerebrovascular accident 1 (6.7) 7 (11.7) 1
Physical examination
Temperature 40 8C or 35 8C 10 (66.7) 26 (43.3) 0.15
Respiratory rate 30 breaths/min 6 (40) 15 (25) 0.34
Heart rate 125 beats/min 6 (40) 22 (36.7) 1
Shock on arrivala 9 (60) 14 (23.3) 0.01
Altered mental status 3 (20) 8 (13.3) 0.68
Initial laboratory data
Sodium <130 mmol/l 4 (26.7) 8 (13.3) 0.24
PaO2 <60 mm Hg 7 (46.7) 27 (45) 1
Band WBC >1% 7 (46.7) 16 (26.7) 0.21
Hematocrit <30% 5 (33.3) 10 (16.7) 0.16
BUN >30 mg/dl 5 (33.3) 16 (26.7) 0.75
CRP >100 mg/dl 10 (76.9)b 20 (50)c 0.12
Chest radiograph ﬁndings
Multilobar inﬁltrates 10 (66.7) 30 (50) 0.39
Presence of a lung cavity 7 (46.7) 8 (13.3) <0.01
Presence of pleural effusion 2 (13.3) 12 (20) 0.72
Inappropriate empirical antibiotic therapy 12 (80) 6 (28.6)d <0.01
Clinical outcomes
Mechanical ventilation 10 (66.7) 32 (53.3) 0.39
Early mortality 7 (46.7) 11 (18.3) 0.04
Overall mortality 10 (66.7) 23 (38.3) 0.02
BUN, blood urea nitrogen; CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; DM, diabetes mellitus; WBC, white
blood cell.
a Multivariate logistic regression analysis indicated that poor sugar control and glycemia 250 mg/dl (OR 38.3, 95% CI 3.6–406.2; p < 0.01), visiting the ED during rainy
season (OR 13.7, 95% CI 2.3–80.9; p < 0.01), and in shock on ED arrival (OR 18.7, 95% CI 1.8–192.8; p = 0.01) were independent risk factors for CAP caused by Burkholderia
pseudomallei.
b Number of patients available for analysis, n = 13.
c Number of patients available for analysis, n = 40.
d Inappropriate empirical antibiotic therapy was found in six (28.6%) of 21 patients with severe CAP from causes other than melioidosis in whom an etiology was identiﬁed.
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empirically treated with quinolones, b-lactam/b-lactamase inhi-
bitors, or extended non-antipseudomonal cephalosporins, which
are the recommended antimicrobial regimens for CAP according to
the current treatment guidelines developed by the Infectious
Diseases Society of America and the American Thoracic Society.12
Although amoxicillin–clavulanic acid is effective against B.
pseudomallei in vitro,2 the clinical condition of the three patients
who received amoxicillin–clavulanic acid therapy deteriorated
rapidly, and they all died within 24 h after ED arrival. An
inadequate dosage (1200 mg every 8 h) of amoxicillin–clavulanic
acid might be one of the reasons for treatment failure. An increased
dosage (amoxicillin–clavulanic acid 20/4 mg/kg intravenous every
4 h) for the treatment of melioidosis to ensure adequate levels of
clavulanic acid has been suggested.13
The early mortality rate of our patients with acute melioid CAP
was 46.7%, which is much higher than the 18.3% mortality rate of
patients with non-melioid CAP, and the mortality rate reported in
another study.14 Pulmonary melioidosis is one of the common
causes of CAP in Southeast Asia. In one study from Singapore, the
incidence of CAP caused by B. pseudomallei was 12.9% among 31
patients with CAP in which organisms were identiﬁed.15 It might
not be wise to follow the general guidelines for the treatment ofCAP in patients with the risk factors for melioid CAP. It is difﬁcult
to differentiate CAP caused by B. pseudomallei from that caused by
other pathogens in the early diagnosis on ED arrival, on the basis of
clinical presentation and chest radiograph ﬁndings (Table 2).
Similar to the cases reported in previous studies,1,2,5,16 DM was
the most common underlying disease in patients with acute
melioid CAP. It is hypothesized that patients with poor sugar
control may have impaired human polymorphonuclear neutro-
phil migration and apoptosis, which explains why poor sugar
control could be a risk factor for acute melioid CAP.17 It is
postulated that B. pseudomallei migrates from the deeper soil
layers to the surface with the rising water table in the rainy
season, thus explaining the association of this season with the
incidence of melioidosis.2 The organism is more common at soil
depths of 30–60 cm than on the soil surface.10 It is possible that
heavy rainfall with strong winds brings buried B. pseudomallei
isolates to the soil surface, and thereafter they are more likely to
be inhaled at high concentrations and cause subsequent pulmo-
nary melioidosis. Thus, clinicians in melioidosis endemic areas
should administer antimicrobials covering B. pseudomallei to
patients with CAP who visit the ED during the rainy season, who
have poor sugar control with glycemia 250 mg/dl, and who are in
shock on ED arrival.
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receive effective treatment.18,19 Deﬁnitive laboratory diagnosis of
melioidosis is based on the isolation of B. pseudomallei. In our
study, the mean duration of time that elapsed before obtaining
culture results conﬁrming B. pseudomallei infection was 5 days
(range 3–7 days). It is noteworthy that 46.7% of the deaths in this
study occurred before a conﬁrmed culture was available. Direct
microscopy using Gram staining may be helpful if typical slender,
pale, bipolar-staining bacilli are observed; however, this technique
lacks speciﬁcity.20 Rapid targeted microbiological work-up, such as
direct microscopy with direct immunoﬂuorescence21 and urinary
antigen enzyme-linked immunosorbent assays,22 may allow a
rapid provisional diagnosis, and thus enable administration of
appropriate antimicrobial therapy. In 2008, we found that patients
with poor sugar control who visited the ED during the rainy season
were at risk of having acute melioid CAP. ED physicians were
inclined to prescribe antibiotics against B. pseudomallei to CAP
patients with hyperglycemia in the rainy season, and also to those
with severe sepsis, until culture results were available. As a result,
three (50%) of the six acute melioid CAP patients enrolled during
the period from 2008 to 2010 received appropriate empirical
antibiotics before a positive culture of B. pseudomallei was
conﬁrmed. Both overall (66.7% vs. 33.3%) and early (50% vs.
33.3%) mortality rates were higher in patients who received
inappropriate empirical antibiotic therapy than in those who
received appropriate empirical antibiotic therapy. This result is
similar to those of several other studies19,23 in which inappropriate
empirical antibiotic therapy has been clearly shown to be an
independent risk factor for mortality in community-acquired as
well as nosocomial-acquired bacteremia. Our report describes the
outcomes of individuals presenting with acute melioid CAP and the
consequences of a wrong antibiotics choice. It provides intriguing
insights for assessing the probability that a patient has acute
melioid CAP in a region where melioidosis is known to be endemic,
albeit uncommon.
Our study has several limitations. First, this paper describes the
hospital course of individuals presenting with acute melioid CAP at
a single institution. The sample size had adequate statistical power
to analyze these risk factors, but CIs were large, which is likely to be
due to the small number of patients. Second, the retrospective
nature of the study inevitably rendered incomplete information
collection regarding the time of diagnosis and the time of initiation
of effective antimicrobial therapy in these patients. Nonetheless,
this study provides intriguing insights for assessing the probability
that a patient has acute melioid CAP early on ED arrival.
In conclusion, patients with a presentation of CAP who have
concomitant poor sugar control, present during the rainy season,
and are in shock upon ED arrival, are at an increased risk of having
acute melioid CAP. Taking into account these ﬁndings allows
appropriate therapy to be started, and may reduce the high
mortality of this condition. We suggest that physicians in areas in
which B. pseudomallei is endemic administer antibiotics for thetreatment of melioidosis to patients with CAP who have the
aforementioned risk factors, until culture results are available.
Conﬂict of interest: The authors have no conﬂict of interest to
declare.
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